Chemosensory dysfunction in COVID-19 out-patients.

María Jesús Rojas-LechugaAdriana Izquierdo-DomínguezCarlos Chiesa-EstombaChristian Calvo-HenríquezIthzel Maria VillarrealGenoveva Cuesta-ChascoManuel Bernal-SprekelsenJoaquim MullolIsam Alobid

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020)

OGD is a prevalent symptom in COVID-19 subjects with significant differences compared to controls. It was predominant in young and females subjects. Stratified analysis by the severity of OGD showed that more than 60% of COVID-19 subjects presented a severe OGD who took a longer time to recover compared to those with mild symptoms.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus
peritoneal dialysis
early onset
middle aged
physical activity